Skip to main content
F3 Platform Biologics, Inc. (JDRR)
F3 Platform Biologics was planning to go public, but the IPO was withdrawn on Jun 20, 2024.
Stock Price: Pending
IPO price not available yet

F3 Platform Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
 20222021
Net Income
-0.93-2.21
Share-Based Compensation
-1.88
Other Operating Activities
0.530.24
Operating Cash Flow
-0.39-0.1
Debt Issued / Paid
0.60.1
Financing Cash Flow
0.60.1
Net Cash Flow
0.210
Free Cash Flow
-0.39-0.1
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).